Skip to main content

Table 1 Baseline characteristics of the study patients

From: Clinical outcomes after pulmonary vein isolation using an automated tagging module in patients with paroxysmal atrial fibrillation

  Overall
(N = 157)
VISITAG (-)
(N = 95)
VISITAG (+)
(N = 62)
P value
Age 56.7 ± 10.9 55.6 ± 11.2 58.5 ± 10.2 0.099
Men 115 (73.2) 70 (73.7) 45 (72.6) > 0.99
BMI 24.6 ± 3.4 24.8 ± 3.1 24.3 ± 3.8 0.339
Previous medical history
Hypertension 51 (32.5) 32 (33.7) 19 (30.6) 0.823
Diabetes 14 (8.9) 8 (8.4) 6 (9.7) > 0.99
Congestive heart failure 3 (1.9) 2 (2.1) 1 (1.6) > 0.99
Vascular disease 4 (2.5) 3 (3.2) 1 (1.6) 0.934
Ischemic stroke/TIA 16 (10.2) 6 (6.3) 10 (16.1) 0.086
CHA2DS2-VASc score 1.2 ± 1.4 1.1 ± 1.4 1.4 ± 1.3 0.284
CHA2DS2-VASc score ≥ 2 54 (34.4) 28 (29.5) 26 (41.9) 0.151
Left ventricular ejection fraction, % 61.0 ± 6.3 61.0 ± 6.1 60.9 ± 6.7 0.905
Left atrial size, mm 39.6 ± 5.5 39.4 ± 4.9 39.9 ± 6.3 0.554
Left atrial volume, ml 112.5 ± 32.9 116.6 ± 31.8 108.0 ± 33.8 0.147
Amiodarone 14 (8.9) 8 (8.4) 6 (9.7) >0.99
Class 1C drug 120 (76.4) 68 (71.6) 52 (83.9) 0.114
Beta-blocker 47 (29.9) 22 (23.2) 25 (40.3) 0.034
Calcium channel blockers 47 (29.9) 32 (33.7) 15 (24.2) 0.275
Digoxin 10 (6.4) 2 (2.1) 8 (12.9) 0.018
  1. BMI body mass index; TIA transient ischemic attack
  2. Data are presented as mean ± standard deviation or number (%)